{"news_desk": "Business", "print_page": "3", "section_name": "Business Day", "subsection_name": "International Business", "byline": {"original": "By DAVID BARBOZA", "person": [{"rank": 1, "role": "reported", "firstname": "David", "organization": "", "lastname": "BARBOZA"}]}, "abstract": "GlaxoSmithKline rehires Vivian Shi, former executive who was once suspected of being whistle-blower that precipitated investigation of its Chinese operations, resulting in nearly $500 million fine; company has since acknowledged widespread misconduct and pledged to revamp operations in country. ", "type_of_material": "News", "word_count": "532", "lead_paragraph": "Vivian Shi, whom GlaxoSmithKline investigated over making allegations of fraud and corruption in China, has rejoined the company.", "pub_date": "2015-08-05T12:30:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Glaxo Rehires Executive Investigated as a Whistle-Blower", "print_headline": "Glaxo Rehires an Executive Linked to Exposing Bribes in China "}, "snippet": "Vivian Shi, whom GlaxoSmithKline investigated over making allegations of fraud and corruption in China, has rejoined the company.", "multimedia": [{"height": 126, "url": "images/2015/08/05/business/gsk-web1/gsk-web1-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/08/05/business/gsk-web1/gsk-web1-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 400, "url": "images/2015/08/05/business/gsk-web1/gsk-web1-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "400", "xlarge": "images/2015/08/05/business/gsk-web1/gsk-web1-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2015/08/05/business/gsk-web1/gsk-web1-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2015/08/05/business/gsk-web1/gsk-web1-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2015/08/05/business/international/glaxo-rehires-executive-linked-to-whistle-blowing.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "GlaxoSmithKline PLC", "name": "organizations"}, {"rank": "2", "is_major": "Y", "value": "China", "name": "glocations"}, {"rank": "3", "is_major": "Y", "value": "Whistle-Blowers", "name": "subject"}, {"rank": "4", "is_major": "Y", "value": "Shi, Vivian", "name": "persons"}, {"rank": "5", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "6", "is_major": "N", "value": "Bribery and Kickbacks", "name": "subject"}], "blog": [], "_id": "55c0990838f0d85dffa32d3f", "source": "The New York Times"}